Biochemical characterization of human HIF hydroxylases using HIF protein substrates that contain all three hydroxylation sites
Melissa B. Pappalardi(GlaxoSmithKline (United States)), Lusong Luo(Beijing Biocytogen (China)), Roland S. Annan(GlaxoSmithKline (United Kingdom)), John D. Martin(Harvard University), Kelly E. Fisher(South College), Huizhen Zhao(University of Pennsylvania), Thau Ho(GlaxoSmithKline (United States)), Robert A. Copeland(Unknown), Peter J. Tummino(Intarcia Therapeutics (United States)), Yong Jiang(GlaxoSmithKline (United States)), Matthew Burns(GlaxoSmithKline (United States)), Dean E. McNulty(GlaxoSmithKline (United States)), Benjamin Schwartz, Sharon Sweitzer(GlaxoSmithKline (United States))
Cited by 37
Related Papers
Identification of a Novel Inhibitor of Mitogen-activated Protein Kinase Kinase
|Journal of Biological Chemistry|1998|3k
Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori
|Nature|1999|1.9k
EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations
|Nature|2012|1.8k
Hydrolysis of Biological Peptides by Human Angiotensin-converting Enzyme-related Carboxypeptidase
|Journal of Biological Chemistry|2002|1.4k
The promise and peril of chemical probes
|Nature Chemical Biology|2015|848